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Abstract
Missense mutations in ATP1A3 encoding Na+,K+-ATPase a3 have been identified as the primary cause of alternating
hemiplegia of childhood (AHC), a motor disorder with onset typically before the age of 6 months. Affected children tend to
be of short stature and can also have epilepsy, ataxia and learning disability. The Na+,K+-ATPase has a well-known role in
maintaining electrochemical gradients across cell membranes, but our understanding of how the mutations cause AHC is
limited. Myshkin mutant mice carry an amino acid change (I810N) that affects the same position in Na+,K+-ATPase a3 as
I810S found in AHC. Using molecular modelling, we show that the Myshkin and AHC mutations display similarly severe
structural impacts on Na+,K+-ATPase a3, including upon the K+ pore and predicted K+ binding sites. Behavioural analysis of
Myshkin mice revealed phenotypic abnormalities similar to symptoms of AHC, including motor dysfunction and cognitive
impairment. 2-DG imaging of Myshkin mice identified compromised thalamocortical functioning that includes a deficit in
frontal cortex functioning (hypofrontality), directly mirroring that reported in AHC, along with reduced thalamocortical
functional connectivity. Our results thus provide validation for missense mutations in Na+,K+-ATPase a3 as a cause of AHC,
and highlight Myshkin mice as a starting point for the exploration of disease mechanisms and novel treatments in AHC.
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Introduction
Alternating hemiplegia of childhood (AHC) is a rare but severe
disease that is difficult to diagnose and even more challenging to
treat. The disease has an estimated prevalence of one case per
million births [1], but this is probably an underestimate caused by
variability in clinical presentation, lack of awareness, and frequent
misdiagnosis as epilepsy or cerebral palsy. Onset of AHC usually
occurs before the age of 6 months, manifesting mainly as ocular
movements and dystonic attacks or an episode of marked
hypotonia [2]. Patients have bouts of hemiplegia or hemiparesis
that last a few minutes to several days [1]. Other paroxysmal
symptoms, such as tonic/dystonic spells or autonomic disturbanc-
es, including alterations in skin colour, temperature, and sweating,
are also present, either concurrent with hemiplegia or in isolation.
Attacks are often precipitated by triggers such as extremes of
temperature, specific foods, physical activity, or exposure to water
or changes in lighting [3]. Proven therapies for amelioration of
episode frequency and duration are extremely limited, and the
long-term impact of even the most frequently prescribed drug
treatment, flunarizine, is unknown [3].
Between episodes, patients present with permanent neurological
symptoms, including poor motor organizational skills, tremor,
ataxia, involuntary abnormal movements, developmental delay
and intellectual disability [3,4]. The hemiplegic attacks in AHC
are reported to be more severe during the first decade, after which
they tend to be milder, whereas cognitive delay becomes more
evident [2]. Among 92 patients who met clinical diagnostic criteria
for AHC, the most frequent non-episodic symptoms were ataxia
(96%) and cognitive impairment (100%), which result in severe
disability as the disease advances [1,3]. Children with AHC are
also prone to a wide range of behavioural and psychiatric
disorders, including impulsivity, attention deficit disorder, difficul-
ties in acquiring speech, obsessionality, and short-temperedness
[1]. None of the treatment interventions has a prominent effect on
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the non-episodic symptoms [4]. The most common finding of
single-photon emission computed tomography (SPECT) and 2-
Deoxy-d-glucose (2-DG) positron emission tomography (PET) is
an interictal decrease in cerebral metabolism [3,5]. AHC patients
also tend to be of short stature and low weight, which may be
related to difficulties in chewing and swallowing [1,4].
Next-generation sequencing has identified 22 different de novo
heterozygous missense mutations in ATP1A3 gene encoding
Na+,K+-ATPase a3 in 103 of 129 (80%) AHC patients studied
[6,7]. AHC patients with ATP1A3 mutations were significantly
more likely to have seizures (54% versus 29%) [7]. The a-subunit
is the catalytic component of the Na+,K+-ATPase, which mediates
the transport of sodium (against its gradient) from the cell cytosol
to the extracellular fluid in exchange for potassium in the opposite
direction (also against its gradient). In each catalytic cycle, three
Na+ ions are actively extruded from the cell in exchange for two
K+ ions per ATP hydrolyzed [8]. Neurones dedicate up to two-
thirds of the energy of ATP hydrolysis just to maintain this active
transport process [9]. Three a-subunit isoforms are expressed in
mammalian brain: a1 in various cell types, a2 predominantly in
astrocytes, and a3 exclusively in neurones [8].
Missense mutations in ATP1A3 were previously identified as the
primary cause of rapid-onset dystonia-parkinsonism (RDP;
DYT12), a disorder characterised by abrupt onset of the
permanent symptoms of dystonia with parkinsonism, often after
a stressful event, typically in late adolescence or early adulthood
[10,11]. No mutations identified to date are shared between the
two disorders, but three AHC-causing mutations affect amino acid
positions also affected by RDP mutations (I274N/T, D801N/Y,
D923Y/N). Nearly all identified AHC mutations affect regions in
or near transmembrane (TM) domains of Na+,K+-ATPase a3,
whereas the RDP mutations are more evenly distributed
throughout the protein. In vitro analyses have shown that RDP
mutations typically reduce Na+,K+-ATPase a3 protein expression
[7,10], whereas AHC mutations caused reductions of 75–90% in
Na+,K+-ATPase activity without affecting the level of Na+,K+-
ATPase a3 expression [7]. RDP mutations, but not AHC
mutations, have been observed in asymptomatic carriers without
identifiable motor symptoms [11]. It has been postulated that
specific amino acid changes might explain the relatively mild and
the late onset clinical phenotype of RDP compared with AHC [6].
Heterozygous amino acid change I810S that was found in a
child with AHC affects the same position in Na+,K+-ATPase a3 as
amino acid change I810N in heterozygous Myshkin (Atp1a3Myk/+;
Myk/+) mutant mice (Figure S1A) [7,12]. I810N results in a
normally expressed but inactive Na+,K+-ATPase a3 enzyme,
which is consistent with the known effects of AHC mutations
[7,12]. Total Na+,K+-ATPase activity (a1 + a2 + a3) in the brains
of Myk/+ mice is reduced by 36–42% [12,13]. Consistent with the
low weight and increased incidence of epilepsy and psychiatric
disorders in AHC patients [1,7,14], Myk/+ mice exhibit an 18%
reduction in body weight, neuronal hyperexcitability with
occasional convulsions [12], and mania-related behaviour respon-
sive to lithium and valproate [13]. When subjected to vestibular
stress, Myk/+ mice exhibit transient tonic attacks and staggering
movements that, in one-third of cases, develop into tonic-clonic
seizures accompanied by epileptic discharges [12]. When bred to
homozygosity, Myk/Myk pups appear grossly normal but die
shortly after birth [12].
Herein, we report the use of molecular modelling of the
structural effects on Na+,K+-ATPase a3 of the I810N Myshkin
mutation in comparison with mutations known to cause AHC or
RDP in human carriers. Following this analysis, we analyzed
heterozygous I810N Myk/+ mice in several behavioural tests of
motor and cognitive function to determine whether they model
any of the permanent symptoms of AHC. Finally, to provide
greater insight into the nature of Na+,K+-ATPase a3 missense
mutation-induced alterations in brain functioning – which may
have translational relevance to AHC – we undertook 2-DG
autoradiographic imaging of I810N Myk/+ mouse brains.
Materials and Methods
Ethics statement
Full details of the study were approved after review by the
University of Leeds Ethical Review Committee and the humane
care and use of mice in this study was carried out under the
authority of the appropriate UK Home Office Project Licence
(40/3447) in accordance with the requirements of the Animals
(Scientific Procedures) Act 1986.
Structural modelling of Na+,K+-ATPase a3 mutations
Wild-type and mutant forms of mouse Na+,K+-ATPase a3 were
modelled by 85% homology with the recently reported crystal
structure of Na+,K+-ATPase a3 with bound potassium and
ouabain (PDB: 2ZXE; previously 3A3Y) from spiny dogfish
(Squalus acanthias) [15], using a homology modelling pipeline built
with the Biskit structural bioinformatics platform [16]. The
mutants included the I810N Myshkin mutation, four AHC
mutations (I274N, D801N, I810S, D923Y) and three RDP
Table 1. Na+,K+-ATPase a3 mutations selected for structural modelling.
Mutation Species Phenotype Na
+,K+-ATPase a3 expression Na+,K+-ATPase a3 activity
HeLa cells[7] COS-7 cells[7] HEK293T cells[10] Mouse brain[12] COS-7 cells[7] Mouse brain[12]
I274N Human AHC n.d. n.d. n.d. n.d. n.d. n.d.
I274T Human RDP Q Q Q n.d. n.d. n.d.
D801N Human AHC = = n.d. n.d. Q n.d.
D801Y Human RDP = = Q n.d. Q n.d.
I810N Mouse Myshkin n.d. n.d. n.d. = n.d. Q
I810S Human AHC n.d. n.d. n.d. n.d. n.d. n.d.
D923N Human RDP = = n.d. n.d. Q n.d.
D923Y Human AHC n.d. n.d. n.d. n.d. n.d. n.d.
Q lower than wild-type; = no significant difference; n.d. not determined.
doi:10.1371/journal.pone.0060141.t001
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mutations (I274T, D801Y, D923N) (Table 1). Our pipeline
workflow incorporates the NCBI tools platform [17], including
the BLAST program for similarity searching of sequence
databases. T-COFFEE [18] was used for alignment of the test
sequence with the template, followed by iterations of the
MODELLER-9.11 program (September 2012 release) [19] to
calculate a structural model. The K+ binding sites were predicted
by superposition of the mouse Na+,K+-ATPase a3 models upon
the 2ZXE structure using the Chimera program [20], which was
also used for the viewing of models and generation of images. It is
not currently possible to predict the position of the Na+ binding
sites due to the lack of a determined Na+ bound structure.
Mice
The Myshkin mouse line has been previously described and was
backcrossed 20 generations to the seizure-resistant C57BL/6NCr
strain (NCI-Frederick) [12,13]; Myk/+ mice at N20 C57BL/6NCr
were previously reported not to show stress-induced seizure
activity during electrocorticography [13]. Mice used in the present
study were bred from C57BL/6NCrl females (Charles River) and
Myk/+ males, and were genotyped by the presence of an EcoO109I
(New England BioLabs) restriction site using polymerase chain
reaction (PCR) primers F, 59-CTG CCG GAA ATA CAA TAC
TGA-39 and R, 59-ATA AAT ACC CCA CCA CTG AGC-39.
Wild-type littermates were used as controls for all experiments. At
4 weeks of age, pups of mixed genotypes were weaned and housed
by sex in groups of three to five. Mice were housed in filtered cages
containing corn cob bedding (Bed-O’-Cobs, Andersons), nesting
material (Nestlets, Ancare) and ad libitum sterile food (2018
Teklad Rodent Diet) and water. Housing conditions were
maintained at 2161uC and 50–60% humidity under a 12:12 h
light-dark cycle (lights on: 0700–1900 hours). Atp1a3Myk/+ mice are
available from the Canadian Mouse Mutant Repository (http://
www.cmmr.ca/mutants_samples/index.html).
Behavioural tests
Behavioural tests were conducted on Myk/+ and +/+ littermates
at 8–12 weeks of age. Male and female mice were included in
experiments in balanced numbers, except for the pawprint
analysis, which included only females because the males were
required to propagate the Myshkin line in a new animal facility.
Subjects were handled daily for 5 min/day for 7 days prior to
behavioural testing. Testing was conducted during the light phase
(0900–1700 hours). Prior to experiments, subjects were left
undisturbed in the testing environment for 30 min to allow for
acclimation. A solution of 70% ethanol or Clidox-S was used to
clean surfaces and equipment between subjects.
Gait analysis. Gait analysis was conducted by coating the
fore and hind paws with two colours of non-toxic paint, and
allowing mice to walk along a narrow, paper-covered runway.
Gait was assessed by analyzing the resulting pawprint patterns, as
described previously [21], except that measurements were
expressed per cm of trunk (defined as the distance between the
forelimbs and hindlimbs) to account for the smaller body size of
Myk/+ mice [12].
Balance beam. Mice were given five training trials on an 80-
cm long, 20-mm wide beam elevated 50 cm above a padded base,
as described previously [21]. A 60-W lamp at the start platform
served as an aversive stimulus, whereas the opposite end of the
beam entered a darkened escape box baited with food pellets. The
number of foot slips and traversal time were measured as mice
traversed the beam in a test trial 24 hours after training.
Tail suspension. Mice were suspended by their tails 30 cm
above a surface for 30-s and observed for hindlimb clasping, a
stereotyped behavioural phenotype indicative of neurological
dysfunction. A mouse was allocated a score = 1 for abnormal
hindlimb movement and score = 0 in the absence of any abnormal
movement in each 10-s epoch, allowing a maximum score of 3.
Abnormal movement was defined as the retraction of either or
both hindlimbs into the body and toward the midline. Wild-type
mice often splay their hindlimbs out when suspended.
Grip strength. The grip strength of all four limbs and the
forelimbs alone was measured using a digital grip strength gauge
(Grip Strength System, San Diego Instruments), as described
previously [21]. The mouse was held by the tail and lowered onto
a wire mesh grid until it could easily grip the grid with all four
limbs or the forelimbs. The tail was then steadily and horizontally
pulled away from the grid until the mouse released its grip. The
maximal force (g) required to relieve the grip was recorded. Each
mouse was subjected to three trials separated by 5-min intervals.
The average score of three trials for each mouse was reported.
Other motor behavioural tests. Tremor was measured
with a commercial tremor monitor (San Diego Instruments)
according to the manufacturer’s instructions. Briefly, mice were
placed in the detection tube and allowed 5 min to habituate. After
habituation, the tremor amplitude was measured for each mouse
for 256 s. The accelerating rotarod test was conducted as
described previously [21], except that mice were given three trials
each day for five consecutive days. Acoustic startle response was
measured as previously described [22]. Data were analysed using
one-way analysis of variance (ANOVA).
Fear conditioning. Experiments were conducted in a fear
conditioning chamber (MED Associates; 25 cm height 630 cm
width625 cm length), and automated fear conditioning software
was used to score behaviour (FreezeFrame 1.6e, Actimetrics). For
the training phase, mice were placed in the chamber for 2 min
followed by a 30-s auditory tone (3600 Hz, 95 dB). Mice received
a continuous scrambled foot shock of either 1.0 mA (Cohort 1) or
0.75 mA (Cohort 2) during the last 2 s of tone and remained in the
chamber for an additional 30 s before being returned to their
home cage. 24 h following training, mice were returned to the fear
conditioning chamber to evaluate their contextual fear memory.
Freezing to the context was recorded for 3 min, and then mice
were returned to their home cage. 26 h following training, the
chamber was altered to evaluate freezing to the auditory tone. The
grid was covered with a smooth white Perspex sheet, the walls
were altered by inserting a white Perspex triangle, a 1% acetic acid
odour was applied and the lights in the room were switched off.
Figure 1. Structural modelling of Na+,K+-ATPase a3 mutations. (A) Na+,K+-ATPase a3 wild-type (left), the I810S mutant (AHC; centre) and the
I810N mutant (Myshkin; right). (B) Na+,K+-ATPase a3 wild-type (left), the I274N mutant (AHC; centre) and the I274T mutant (RDP; right). Side chain
contact between D272 and D274 at the cytoplasmic end of the K+ pore is shown in yellow for the wild-type protein and the I274T mutant, but this
contact is lost in the I274N mutant. (C) Na+,K+-ATPase a3 wild-type (left), the D801N mutant (AHC; centre) and D801Y mutant (RDP; right). In the
D801N mutant, the electrostatic interaction at D801 with both K+ ions is lost due to replacement of terminal oxygen with nitrogen, resulting in the
obstruction of the K+ pore, likely to markedly affect conductance rates through the pore, while the interaction of K+2 with E776 is maintained. In the
D801Y mutant, there is a predicted loss of interaction of K+2 with E776. (D) Na+,K+-ATPase a3 wild-type (left), the D923Y mutant (AHC; centre) and the
D923N mutant (RDP; right).
doi:10.1371/journal.pone.0060141.g001
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Subjects were placed in a chamber for 3 min to explore the new
environment, followed by a 3 min presentation of the auditory
tone while freezing was recorded. Data were analysed using one-
way ANOVA and Student’s two-sample t test.
Conditioned taste aversion. The CTA procedure was
adapted from a previously published method [23]. For the 7-day
duration of the CTA procedure, mice were group housed and
water-deprived with free access to food. During testing sessions
that occurred once every 24 hours, mice were placed individually
into separate cages that contained drinking bottles. During a 5-day
habituation period, mice were trained to drink their daily water
ration from two bottles containing room temperature autoclaved
water within 30 min (Day 1, 120 min access to water; Days 2 and
3, 60 min access; Days 4 and 5, 30 min access). On the
conditioning day, a novel taste (the CS; 0.1% w/v saccharin
sodium salt) was paired with the malaise-inducing agent LiCl
(0.3 M, 2% body weight, i.p.). Placement of the CS solution bottle
(left vs. right) was counterbalanced across mice. The CS fluid was
presented for 30 min and, 40 min later, mice were treated with
LiCl or a similar volume of saline. Testing occurred 24 h later,
when two bottles (one bottle containing water and the other
containing the CS fluid) were presented for 30 min. The intake of
each fluid was measured. The degree of CTA learning was
determined for each mouse by a CS consumption score: the
amount of CS solution consumed divided by the total amount of
fluid (CS + water) consumed. Data were analysed using two-way
ANOVA.
Assessment of [14C]-2-deoxyglucose utilization
An injection of 80 mCi/kg [14C]-2-deoxyglucose (specific
activity 56 mCi/mmol; GE Healthcare) in sterile saline was
administered interperitoneally at a volume of 10 ml/kg to Myk/+
(n = 10) and +/+ (n = 8) mice, as described previously [24,25].
Forty-five minutes after 2-DG administration, mice were decap-
itated and the brains rapidly removed, snap-frozen in isopentane
cooled to 242uC, and stored at 270uC until preparation of
sections for autoradiographic analysis.
Tissue was sectioned in the coronal plane using a cryostat
(20 mm) throughout the whole brain. Sections were thaw-mounted
onto slides and immediately placed on a slide heater at 65uC to
ensure rapid desiccation and prevent lateral diffusion of 2-DG.
Slides along with 14C standards were then sealed within
autoradiographic cassettes and opposed to beta-sensitive film
(Kodak) for 21 days at 280uC. Films were developed using an
automatic processor (Konica) prior to analysis using MCID 6.0
Elite image analysis system software (MCID). Densiometric
analysis of each section was carried out whereby a reference
curve of [14C] (nCi/g) versus optical density was calculated from
the coexposed beta-emitting [14C] microscale standards and used
to quantify the density signal for each brain region into its [14C]
Figure 2. Motor dysfunction inMyk/+mice. (A) Gait analysis. Left panel: Mean fore stride and hind stride distance (6 SEM) per cm trunk of Myk/+
(n= 14) and +/+ (n= 17) female mice. There were significant main effects of genotype on fore stride length (F1,30 = 5.59, P = 0.025), hind stride length
(F1,30 = 8.09, P = 0.008) and hind stride width (F1,30 = 24.44, P = 0.0001) (left panel). Middle panel: Typical examples of forepaw (red) and hindpaw (blue)
placement of Myk/+ and +/+ mice are shown. Scale bar = 2 cm. Right panel: Myk/+ mouse showing splayed hindlimbs. (B) Balance beam. Mean
number of foot slips (left panel) and traversal time (right panel) (6 SEM) of Myk/+ (n= 26) and +/+ (n= 45) mice when traversing a narrow beam
24 hours after training. There were significant main effects of genotype on number of foot slips (F1,70 = 99.46, P = 0.0001) and traversal time
(F1,70 = 43.38, P= 0.0001). (C) Tail suspension. Mean hindlimb retraction score (6 SEM) ofMyk/+ (n= 26) and +/+ (n= 26) mice suspended by the tail for
30 s. There was a significant main effect of genotype (F1,51 = 29.00, P = 0.0001). Hindlimb retraction is defined as the movement of one of both
hindlimbs into the central body axis (photograph). (D) Accelerating rotarod. Mean latency (6 SEM) of Myk/+ (n= 18) and +/+ (n= 21) mice to fall from
a rotating rod over three training trials. There were significant main effects of sex (F1,38 = 9.94, P= 0.003) and genotype (F1,38 = 6.09, P= 0.019), but not
genotype x sex interaction (F1,38 = 0.91, P = 0.346), females performing better than males regardless of genotype. (E) Tremor. Mean amplitude of
displacement (6 SEM) of Myk/+ (n= 36) and +/+ (n= 52) mice across a spectrum of frequencies. There was a significant main effect of genotype on
frequency at the maximal amplitude (F1,87 = 57.1, P = 0.0001). *P,0.05; **P,0.01; ****P,0.0001 versus +/+ mice.
doi:10.1371/journal.pone.0060141.g002
Figure 3. Cognitive impairment in Myk/+ mice. (A) Fear
conditioning with 1.0-mA footshock. Mean freezing levels (6 SEM) of
Myk/+ (n= 24) and +/+ (n= 25) mice at baseline, during training, and in
the contextual and cued conditioning tests. There were significant main
effects of genotype on freezing in the context test (F1,48 = 8.52,
P = 0.005) and in the cue test during presentation of the auditory tone
(CS; F1,48 = 6.20, P = 0.016). (B) Conditioned taste aversion. Mean (6 SEM)
CS consumption scores (intake of saccharin/total fluid) 24 h following
pairing with LiCl or saline treatment in Myk/+ and +/+ mice. There were
significant main effects of genotype (F1,47 = 6.51, P = 0.014), treatment
(F1,47 = 48.12, P = 0.0001), and genotype x treatment interaction
(F1,47 = 4.09, P= 0.049). *P,0.05; ***P,0.001; ****P,0.0001 versus +/+
mice.
doi:10.1371/journal.pone.0060141.g003
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concentration. Background intensity was subtracted from each
reading. Values were obtained from 45 regions of interest (RoI)
throughout the brain (including the cerebellum) with reference to a
stereotaxic mouse brain atlas [26]. Regional glucose metabolism
was estimated as the 14C concentration in each RoI relative to the
whole-brain average 14C level (defined as the average concentra-
tion of 14C across all analysed regions) in the same mouse,
consistent with published reports using the same semi-quantitative
2-DG approach [25]. Significant differences in regional metabo-
lism between Myk/+ and +/+ mice were assessed using Welch’s t-
test, which was used due to unequal variances in the samples. In
line with previous protocols [25], the functional connectivity of
defined ‘‘seed’’ RoI was determined in Myk/+ and +/+ mice using
the partial least squares regression algorithm (PLSR). PLSR
analysis was completed using the PLS package in R [27,28].
‘‘Seed’’ RoI were selected on the basis of a significant difference in
overt local cerebral glucose utilization (LCGU) between Myk/+
and +/+ mice. In this way, Myk/+-induced alterations in the
functional connectivity of the frontal cortex (FCTX), three
thalamic nuclei (ventral anterior thalamic nucleus [VAthal],
ventromedial thalamic nucleus [VMthal], ventral posteromedial
thalamic nucleus [VPMthal]), two subfields of the periaqueductal
grey (dorsomedial [DMPAG] and rostral [RPAG]), and the caudal
motor cortex (CMCTX) were considered. The functional
connectivity of each ‘‘seed’’ region (dependent variable in the
PLSR model) to all of the other RoI measured (explanatory
variables; 44 brain regions in each analysis) was considered in
terms of the variable importance to the projections (VIP) statistic.
Within each experimental group, and for each ‘‘seed’’ region, a
significant functional connection between brain regions was
considered to exist if the 95% confidence interval (CI) for the
VIP statistic exceeded 0.8, because this threshold denotes a
considerable contribution of an explanatory variable to the
dependent variable in PLSR models. The standard deviation
(SD) and CI for the VIP statistic were estimated by jackknifing.
The significance of Myk/+ induced alterations in functional
connectivity (the VIP statistic) was analyzed by comparison to
the real difference in the VIP statistic between experimental
groups relative to that in 1,000 random permutations of the raw
data. Significance was set at P,0.05 throughout.
Measurement of arterial blood pressure
Arterial blood pressure (mean, systolic, and diastolic) and heart
rate were measured by radiotelemetry, as previously described
[29]. The probe catheter was advanced into the ascending aorta
via the left carotid artery. Twenty-four-hour recordings were
obtained by sampling for 2 min every 15 min. For Millar catheter
analysis, a pressure–volume catheter was inserted into the left
ventricle via the right carotid artery. Data were analysed using
Student’s t test.
Results
Myshkin and AHC mutations have greater impacts than
RDP mutations on Na+,K+-ATPase a3 structure
To investigate a potential structural rationale for the disease
phenotype pertaining to each missense mutation of Na+,K+-
ATPase a3, we undertook comparative molecular modelling of the
I810N Myshkin mutation along with the AHC mutations and RDP
mutations affecting the same positions (Table 1). All the mutations
studied affect transmembrane helices bordering the K+ pore
(Figure S1B). Mechanisms for deleterious effects can be readily
postulated for all the Myshkin, AHC and RDP mutations, though
there is a consistent pattern of the AHC mutations and Myshkin
Figure 4. Significant alterations in overt local cerebral glucose utilization in Myk/+ mice. Data shown as mean 6 SEM of the 14C-2-DG
uptake ratio. *denotes P,0.05, **denotes P,0.01 and ***denotes P,0.001 significant genotype effect (Welch’s t-test).
doi:10.1371/journal.pone.0060141.g004
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Figure 5. Thalamocortical, thalamostriatal and intrathalamic functional connectivity in Myk/+mice. Summary diagrams showing altered
functional connectivity of (A) frontal cortex (FCTX), (B) ventral anterior thalamic nucleus (VAthal), (C) ventromedial thalamic nucleus (VMthal), and (D)
ventral posteromedial nucleus (VPMthal) in Myk/+ mice. Only regions where the 95% CI of the VIP exceeded 0.80, in either Myk/+ or +/+ mice, were
considered to be functionally connected to the defined ‘‘seed’’ region of interest. The I810N Myshkin mutation-induced alterations in functional
connectivity were analysed by permutation test (1000 random permutations of the real data) with significance set at P,0.05. Red denotes a
significant increase, whereas blue denotes a significant decrease, in regional functional connectivity in Myk/+ mice relative to +/+.
doi:10.1371/journal.pone.0060141.g005
Figure 6. Altered periaqueductal grey and caudal motor cortex functional connectivity in Myk/+ mice. Summary diagrams showing
altered functional connectivity of (A) dorsomedial (DMPAG) and (B) rostral (RPAG) periaqueductal grey, and (C) caudal motor cortex (CMCTX) in Myk/+
mice. Only regions where the 95% CI of the VIP exceeded 0.80, in either Myk/+ or +/+ mice, were considered to be functionally connected to the
defined ‘‘seed’’ region of interest. The I810N Myshkin mutation-induced alterations in functional connectivity were analysed by permutation test
(1000 random permutations of the real data) with significance set at P,0.05. Red denotes a significant increase, whereas blue denotes a significant
decrease, in regional functional connectivity in Myk/+ mice relative to +/+.
doi:10.1371/journal.pone.0060141.g006
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displaying more severe structural impacts than the RDP mutations
affecting the same positions, notably upon the K+ pore and
predicted K+ binding sites. It is likely that there are significant
impacts upon Na+ binding and transport too, but these cannot
currently be definitively predicted by molecular modelling, due to
the lack of a Na+ bound Na+,K+-ATPase structure.
The AHC mutation, I810S, imparts similarly severe structural
consequences upon pore architecture as the Myshkin mutation,
I810N, by substitution of a hydrophobic residue bordering the
pore with a polar side chain, affecting the routing of K+ ions. The
I810S substitution leads to the loss of interaction of E776 with its
K+ ion and the introduction of an oxygen end group to the vicinity
of the pore at S810. The I810N substitution also disrupts the
interaction of E776 with its K+ ion, and introduces a polar end
group to the pore (Figure 1A).
The AHC I274N substitution brings about loss of interaction of
E776 with its K+ ion and introduction of a polar side chain into
the K+ pore at N274. There is also a loss of side chain contact
between D272 and D274 at the cytoplasmic end of the K+ pore,
compared to the wild-type. With the RDP I274T mutation, a
relatively hydrophobic side chain is incorporated and a similar
D272-D274 contact to wild-type is found (Figure 1B).
In the wild-type protein, D801 is located directly between the
predicted binding sites for the two K+ ions at the centre of the
transmembrane domain of the protein. E776 interacts with one of
the K+ ions (1.95A˚). The profound impact of the substitution of
D801 by the very similar asparagine (N) residue is due to the most
common AHC mutation, D801N [6,7], directly affecting the main
K+ binding site of the protein. Interestingly, the substitution of
D801 by tyrosine (Y), a more conspicuous substitution in terms of
residue physicochemical properties and size difference, might
result in a lesser impact on K+ conductance than D801N.
Although the RDP D801Y mutation drastically affects binding at
one of the K+ binding sites, passage through the pore remains
unaffected. Y801 is predicted to occupy the position of one of the
K+ ions, preventing binding there, while the passage of the other
K+ ion is unaffected, leaving the K+ pore less obstructed than for
D801N. In contrast, D801N introduces the positive dipole of the
terminal amino group directly between the two K+ ions at the
primary binding site, potentially repelling binding events and
passage of both ions (Figure 1C).
Finally, the AHC D923Y mutation directly leads to a loss of
negative charge bordering the K+ pore, along with dramatic
spatial conflicts between Y923 and Y768 (projected overlap 0.7A˚),
with a significant impact on interhelical packing of TM8 and TM5
likely, and subsequently upon the orientation of TM5 around the
K+ pore. With the RDP D923N mutation, there is also
replacement of the negative charge of aspartic acid (D) bordering
the K+ pore but with a highly polar group of the very similar
asparagine (N), with highly similar orientation too. There is
consequently no effect on interhelical packing of TM8 and TM5
in the case of D923N (Figure 1D).
Motor dysfunction in Myk/+ mice
Myk/+ mice of both sexes exhibit an unsteady, tremorous gait
with occasional splaying of the hindlimbs from weaning (separa-
tion from the dam) at about 4 weeks of age (Figure 2A; Video S1,
S2). Given the finding that the Myshkin mutation, I810N, imparts
similarly severe structural consequences upon Na+,K+-ATPase a3
pore architecture as the AHC mutation, I810S, we proceeded to
quantify the motor phenotype of Myk/+ mice in several
behavioural tests.
Before conducting gait analysis, we compared the trunk length
(defined as the distance between the forelimbs and hindlimbs) of
Myk/+ and +/+ female mice as a measure of body size, since
Myk/+ mice exhibit an 18% reduction in body weight [12]. Myk/+
mice had a significantly shorter trunk than +/+ mice (Myk/+
5.6160.19 cm versus +/+ 6.8560.14 cm; F1,30 = 28.42,
P= 0.0001; Figure S2A). Gait analysis with adjustment for the
genotypic difference in body size showed that, proportionately,
Myk/+ mice walk with shorter strides and a broader base of the
hindlimbs than their larger +/+ littermates (Figure 2A; unadjusted
data in Figure S2B–F).
In the balance beam task, Myk/+ mice performed poorly and
exhibited severe tremors and ataxic movement when walking
across the beam. Some Myk/+ mice exhibited ‘hindlimb dragging’
at the start of training: their thorax and abdomen were flattened
against the upper surface of the beam, their hindlimbs and tail
were laterally wrapped around the beam, and their forelimbs were
used to drag themselves along. In a trial 24 hours after training,
the number of foot slips and the latency to traverse the beam were
both significantly increased in Myk/+ mice compared with +/+
littermates (Figure 2B). In response to tail suspension, Myk/+ mice
displayed frequent paroxysmal bouts of hindlimb clasping and
trunk flexion within the 30 s period of observation, indicative of
neurological disease of a generalized nature; 18 of 26 Myk/+ mice
(69%) displayed at least one bout of hindlimb retraction compared
with 2 of 26 of +/+ mice (8%) (Figure 2C). In the accelerating
rotarod test, mice were given three trials each day for five
consecutive days. On the first day, when subjects were naı¨ve to the
task, Myk/+ mice had difficulty remaining on the rotating rod and
had a significantly shorter latency to fall than +/+ mice
(Figure 2D). However, on the four subsequent days, we found
no genotypic differences in performance on the accelerating
rotarod (Figure S3A). Quantitative tremor monitoring revealed
that the tremor of Myk/+ mice has a maximal amplitude at
22.6761.079 Hz, which contrasts to the normal physiologic
tremor of 13.5260.68 Hz detected in +/+ mice (Figure 2E).
To test whether the motor dysfunction of Myk/+ mice was
related to muscle weakness, we measured grip strength. There was
no genotypic difference in forelimb strength among either sex, or
strength of all four limbs among females. However, Myk/+ males
required 11.762.6% less force to release all four paws from a wire
grid (Figure S3B), but this difference was not maintained when
grip strength was expressed per g of body weight (Myk/+
15.0160.37g versus +/+ 14.1760.38g; F1,49 = 2.36, P= 0.131).
Grip strength of forelimbs and all four limbs showed a significant
positive correlation with body weight in both genotypes
(Figure S3C, D).
Cognitive impairment in Myk/+ mice
To evaluate the cognitive abilities of Myk/+ mice, we used two
behavioural tests of associative learning and long-term (24-hour)
memory. Fear conditioning tests an animal’s ability to learn and
remember an association between an environment and foot shock
(contextual fear conditioning), or between an auditory tone cue
(the conditioned stimulus, CS) and foot shock (cued fear
conditioning). The procedure takes advantage of the natural
tendency of rodents to suppress any movement besides respiration
and heartbeat (freezing) in response to fearful stimuli. In the fear
conditioning chamber, both genotypes showed similarly low levels
of baseline freezing. In the contextual fear conditioning test, a day
after mice had received a 1-mA footshock, both genotypes showed
significantly increased levels of freezing relative to baseline freezing
(P,0.0001), but Myk/+ mice showed a significantly lower level of
freezing in the context than +/+ mice (Figure 3A). In the cued fear
conditioning test, the freezing level of both genotypes in the altered
context prior to presentation of the auditory tone (Pre-CS) was
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significantly greater than baseline freezing (P,0.0001), suggesting
that both genotypes showed some fear response to the altered
context. During presentation of the auditory tone (CS), both
genotypes increased their freezing levels relative to Pre-CS
freezing (P,0.0001), although Myk/+ mice showed a significantly
lower level of CS freezing than +/+ mice (Figure 3A). To
investigate the effect of a less noxious stimulus on the apparent fear
conditioning deficit of Myk/+ mice, we subjected a fresh cohort of
mice to fear conditioning with a 0.75 mA footshock. The freezing
levels of both genotypes were reduced, but the significantly lower
levels of contextual freezing and CS freezing of Myk/+ mice were
maintained (Figure S3E). Despite the stressful nature of the fear
conditioning test, Myk/+ mice did not exhibit convulsions during
this procedure.
Acoustic startle is a motor reflex response to an intense loud
noise stimulus. Given the reduced cued fear conditioning of Myk/+
mice, we assessed their acoustic startle response as a measure of
gross hearing ability. There was no effect of genotype on startle
responses to brief (40 ms) white noise bursts of 85–120 decibels
(dB), but male Myk/+ mice showed an enhanced startle response at
lower sound volumes (70–80 dB) (Figure S3F).
As a secondary test of learning and memory, we used a measure
of associative learning known as conditioned taste aversion (CTA),
which involves animals recognizing a novel taste as aversive when
it has been associated with post-ingestive malaise. A novel taste
(conditioned stimulus, CS; saccharin solution) was paired with the
gastric malaise-inducing agent lithium chloride (unconditioned
stimulus, US; LiCl). 24 hours following pairing with LiCl, the
degree of CTA learning was determined by a CS consumption
score (intake of saccharin/total fluid), a low score indicating
relatively little consumption of the CS and, consequently, a strong
CTA. After treatment with LiCl, both genotypes showed an
aversion to saccharin compared to vehicle-treated mice, but Myk/
+ mice had a higher CS consumption score and thus a weaker
CTA than +/+ mice (Figure 3B). Myk/+ and +/+ mice consumed
similar total levels of fluid in the test session (data not shown).
Altered regional cerebral metabolism and functional
connectivity in Myk/+ mice
We undertook 2-DG imaging of the brains of Myk/+ mice to
determine the effect of the I810N Na+,K+-ATPase a3 mutation on
cerebral glucose metabolism. We found significantly decreased
overt cerebral glucose metabolism in the frontal cortex (FCTX:
222%, P= 0.016), multiple thalamic nuclei (ventral anterior
nucleus [VAthal]: 218%, P= 0.040; ventral posteromedial
nucleus [VPMthal]: 222%, P= 0.005; ventromedial nucleus
[VMthal]: 219%, P= 0.031) and caudal motor cortex (CMCTX:
218%, P= 0.017) in Myk/+ as compared to +/+ mice. By
contrast, cerebral glucose metabolism was profoundly increased in
the periaqueductal grey (PAG) of Myk/+ as compared to +/+ mice
(Rostral PAG [RPAG]: +75%, P= 0.041 and dorsomedial PAG
[DMPAG]: +46%, P= 0.016) (Figure 4). Full data for overt
cerebral glucose metabolism are shown in Table S1.
Partial least squares regression (PLSR) analysis revealed
decreased thalamocortical and thalamostriatal functional connec-
tivity in Myk/+ mice relative to their +/+ littermates. Analysis of
frontal cortex (FCTX) connectivity revealed a significant decrease
in the functional connectivity of this region to multiple thalamic
nuclei including the ventral anterior thalamic nucleus (VAthal),
ventromedial thalamic nucleus (VMthal) and ventral posterome-
dial thalamic nucleus (VPMthal) in Myk/+ relative to +/+ mice. By
contrast, the functional connectivity of the FCTX to the superior
colliculus (SupC) was significantly enhanced in Myk/+ mice
(Figure 5A).
Reduced thalamocortical functional connectivity in Myk/+ mice
is further supported by the observation that all three thalamic
nuclei considered as ‘‘seed’’ regions in PLSR analysis (VAthal,
VPMthal and VMthal) showed reduced functional connectivity to
multiple cortical regions, including the FCTX, rostromedial motor
(RMCTX) and somatosensory cortex (SSCTX). In addition, all
three thalamic regions showed significantly reduced connectivity
to multiple subfields of the striatum, with connectivity to the
caudal dorsomedial striatum (CDMStr) being significantly reduced
for all three thalamic ‘‘seed’’ regions. By contrast, there was
evidence for abnormally enhanced intrathalamic functional
connectivity in Myk/+ mice that included enhanced connectivity
between all three of the considered thalamic ‘‘seed’’ regions
(Figure 5B–D). Full data for thalamocortical functional connec-
tivity are shown in Table S2, S3, S4, S5.
The functional connectivity of the periaqueductal grey (PAG)
was also profoundly altered in Myk/+ mice, as evidenced by the
altered functional connectivity of the dorsomedial (DMPAG) and
rostral (RPAG) periaqueductal grey (Figure 6). There was evidence
that the functional connectivity between these two PAG regions
was significantly decreased in Myk/+ mice. This resulted in the
DMPAG showing increased functional connectivity to the locus
coeruleus (LC), a primary source of noradrenergic innervation to
the PAG, but a decreased functional connectivity to multiple
hippocampal subfields (CA1, CA3) and the entorhinal cortex (EC),
a cortical region with dense reciprocal connections to the
hippocampus (Figure 6A). By contrast, the functional connectivity
of the RPAG with the hippocampus was not altered. Rather, this
PAG subfield, being functionally disconnected from the DMPAG
in Myk/+ mice, showed reduced connectivity to regions of the
basal ganglia (globus pallidus [GP], substantia nigra pars reticulata
[SNR]) and the thalamus (VLthal). In addition, the RPAG showed
increased connectivity to the superior colliculus (SupC and the
superficial grey layer of the superior colliculus [SGSupC]) in Myk/
+ mice relative to +/+ controls (Figure 6B).
The caudal motor cortex (CMCTX) showed a complex pattern
of altered functional connectivity to multiple neural systems in
Myk/+ mice. This included reduced functional connectivity to the
LC, reduced connectivity to the striatum (caudal ventrolateral
striatum [CVLStr]), and a contrasting enhancement in functional
connectivity to components of the visual system (SupC) (Figure 6C).
Full data for periaqueductal grey and caudal motor cortex
functional connectivity are shown in Table S6, S7, S8.
Elevated arterial blood pressure in Myk/+ mice
Since chronic intracerebroventricular (ICV) infusion of the
specific Na+,K+-ATPase inhibitor ouabain, but not the same dose
given subcutaneously, has been shown to activate the orthosympa-
thetic nervous system and elevate blood pressure in wild-type mice
[30], we measured the heart rate and arterial blood pressure of
Myk/+ mice. We found that Myk/+ mice had elevated mean,
systolic, and diastolic blood pressure compared to +/+ littermates
(Figure S4), whereas heart rate was not significantly different
between genotypes (Myk/+ 578.7633.8 bpm versus +/+
555.0610.2 bpm; P= 0.269).
Discussion
Overall, a consistent structure-phenotype relationship emerged
from our comparative molecular modelling of AHC and RDP
mutations affecting the same positions in Na+,K+-ATPase a3. The
AHC mutations, D801N, I810S, I274N and D923Y, as well as the
I810N Myshkin mutation, all bring about structural changes that
severely affect capacity for efficient K+ movement along the
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narrow corridor of the K+ pore. The RDP mutations at the same
positions, namely D801Y, I274T and D923N, have somewhat
milder structural impacts that are likely to result in impaired K+
conductance, but not to the extent of the AHC mutations. This
finding supports the notion that specific amino acid changes
explain the relatively mild and the late onset clinical phenotype of
RDP compared with AHC [6].
Examination of structural homologues of the mouse Na+,K+-
ATPase a3 reveals that the cytoplasmic Na+ binding site of the
rabbit sarcoplasmic calcium ATPase (PDB: 2DQS, Toyoshima
and colleagues) is in an almost identical position, indeed just
alongside when superimposed, to the cytoplasmic K+ binding site
in the main modelling template used here, the spiny dogfish
Na+,K+-ATPase (PDB: 2ZXE, [15]). There is no atomic
information for the transmembrane region binding sites of Na+
for any of the Na+,K+-ATPases, though sections of the TM5, TM6
and TM8 regions have been implicated in cytoplasmically facing
Na+ binding sites [31–33], which complements our deductions
regarding the importance of E776 (TM5), D801 and I810 (TM6),
and D923 (TM8) in K+ binding. It is conceivable that, when the
Na+ binding sites are eventually elucidated, they may share
structural elements with the K+ pore, the two cations perhaps
using similar corridors on their way through the membrane. Our
deductions from structural modelling regarding the impact of these
mutations on K+ transport are balanced by awareness that the
mutations may well also impact, or even primarily impact, upon
Na+ transport. The disease phenotypes may be a manifestation of
disruption of the movement of either or both cations.
Na+,K+-ATPases are functionally regulated by cyclic AMP-
activated protein kinase A (PKA) phosphorylation on a well-
conserved serine residue (S933 in a3; S943 in a1) in the
cytoplasmic loop between TM8 and TM9 [34,35]. S933 is the
only well-characterized phosphorylation target in the Na+,K+-
ATPase [34], but several other phosphorylation sites have been
detected by mass spectrometry [36]. Although the change to a
serine imparted by mutation I810S in AHC [7] raises the
theoretical potential for novel phosphorylation to occur on the
S810 mutant a3, the NetPhos online tool for predicting potential
phosphorylation sites (www.cbs.dtu.dk/services/NetPhos) [37]
does not predict an additional serine phosphorylation site on
S810 (AHC) compared to N810 (Myshkin) and I810 (wild-type)
Na+,K+-ATPase a3.
No animal model is currently available for ATP1A3-associated
AHC. However, our finding that the I810N Myshkin mutation
imparts similarly severe structural consequences upon pore
architecture as the AHC mutation, I810S, establishes the
aetiological relevance of Myk/+ mice to AHC. Based on this
finding, we proceeded to analyse Myk/+ mice for signs of the
permanent (non-episodic) symptoms of AHC.
Our observation that Myk/+ mice have a significantly shorter
trunk and lower body weight than +/+ mice is consistent with the
tendency of AHC patients to be of short stature and low weight, in
comparison to mean values according to age [1,4]. Decreased
body size/weight has also been observed in other mice with ataxia
and tremor, such as the classical neurological mutants frissonnant
(Kcnn2fri) [38], reeler (Relnrl) [39], trembler (Pmp22Tr) [40] and weaver
(Kcnj6wv) [41]. Studies to elucidate the cause of the low body weight
found decreased circulating levels of IGF-I in weaver mice [41], but
unaltered circulating levels of growth hormone (GH) in reeler mice
[39]. It has been postulated that the restricted growth of AHC
patients is almost certainly because of insufficient calorie intake
caused by difficulties in feeding and swallowing [1], but a specific
study of energy metabolism would be required to investigate the
nutrition of Myk/+ mice.
In two large surveys of AHC patients, the most common
permanent symptoms were ataxia and cognitive impairment [3,4].
We observed that Myk/+ mice exhibit an unsteady, tremorous gait
from about 4 weeks of age. We did not observe overt hemiplegia in
Myk/+ mice, but their occasional splaying of the hindlimbs
potentially models the episodes of bilateral weakness reported by
86.5% of AHC patients [4]. In common with AHC, episodic
hemiplegia or hemiparesis is a clinical feature of familial
hemiplegic migraine type 1 (FHM1), an autosomal dominant
disorder caused by missense mutations in the CACNA1A gene
encoding the pore-forming a1A-subunit of neuronal, voltage-gated
CaV2.1 calcium channels [42]. Homozygotes or heterozygotes of
two knock-in FHM1 mouse models carrying human pathogenic
missense mutations appear phenotypically normal and did not
exhibit neurological deficits when assessed using a wire grip test
and neurological examination protocols [43]. In common with
Myk/+ mice, homozygous FHM1 mutant mice did not display
overt hemiplegia, and only exhibited leaning and circling
behaviour and wire grip deficits after topical application of KCl
onto the occipital cortex following burr hole surgery [44].
We quantified the motor phenotype of Myk/+ mice in several
behavioural tests that, in aggregate, assess overlapping aspects of
sensorimotor function such as motor power, coordination, and
postural stability. Gait analysis showed that the length and width
of the forelimb stride and the length of the hindlimb stride are
significantly smaller in female Myk/+ mice as compared to +/+
littermates, with no difference in the width of the hindlimb stride.
However, adjustment of these data for the genotypic difference in
body size revealed that, proportionately, Myk/+ mice walk with
shorter strides and a broader base of the hindlimbs. For technical
reasons, male Myk/+ mice were not available for the gait analysis,
but the unsteady gait exhibited by Myk/+ mice of both sexes
suggests that abnormal pawprint patterns may not be restricted to
Myk/+ females.
Myk/+ mice performed poorly in the balance beam task that
assesses a mouse’s ability to maintain balance while traversing a
narrow beam to reach a safe platform. In the accelerating rotarod
test, mice are placed on the rod and their latency to fall provides a
Figure 7. Summary diagram of alterations in brain system
functional connectivity and overt alterations in regional
cerebral glucose metabolism seen in Myk/+ mice. Blue shading
of neural systems indicates a significant decrease in overt cerebral
metabolism while red denotes a significant increase in overt cerebral
metabolism (Figure 4). Blue/broken arrows indicate a decrease in
functional connectivity between and within (periaqueductal grey
subfields) neural systems in Myk/+ mice relative to +/+ littermates. Red/
solid arrows indicate increased functional connectivity between and
within (thalamic nuclei) neural systems in Myk/+ mice relative to +/+
littermates.
doi:10.1371/journal.pone.0060141.g007
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measurement of their motor coordination. Myk/+ mice had a
significantly shorter latency to fall than +/+ mice on the first day of
the rotarod test, demonstrating impaired motor coordination.
However, Myk/+ mice showed no differences in performance on
the four subsequent days of testing, demonstrating an intact ability
to acquire new motor skills (motor learning). Mouse weight is
reported to be a common confound of the rotarod test, heavy mice
performing worse than light mice, such that genetic or lesion-
induced weight loss can offset motor disability and potentially skew
results [45]. Although the performance of Myk/+ mice on the
rotarod may have been worse were it not for their significantly
lower body weight, transgenic mouse models of DYT1 torsion
dystonia and DYT11 myoclonic dystonia have also been reported
to show deficits on the balance beam but normal motor learning
on the rotarod [46–48].
Myk/+ mice showed deficits in contextual fear conditioning and
cued fear conditioning in tests using two different footshock
currents, with the higher amplitude footshock eliciting a stronger
freezing response. The robust startle responses of Myk/+ mice to
auditory stimuli of 70–120 dB in the acoustic startle test suggest
that the reduced freezing of Myk/+ mice cannot be attributed to a
reduced capacity to hear the 95-dB auditory tone during the fear
conditioning procedure. Moreover, our previous finding that
Myk/+ mice show normal head tracking in an optokinetic drum
suggests that their vision is not impaired [13]. The mean freezing
level of 55% of Myk/+ mice in the cued fear conditioning test
suggests that their ability to exhibit freezing was not grossly
affected by their whole body tremor. Nevertheless, we measured
conditioned taste aversion (CTA) as a secondary test of learning
and memory that does not rely on an ability to suppress
movement. We found that, compared to +/+ mice, Myk/+
mutants demonstrated a weaker CTA, a form of implicit memory
that can be acquired even after massive damage to the
hippocampus [49,50].
By contrast with Myk/+ mutants, mice heterozygous for a point
mutation in Atp1a3 intron 4 (Atp1a3tm1Ling/+) – which reduces
hippocampal a3 expression by ,60% and total brain Na+,K+-
ATPase activity (a1 + a2 + a3) by ,16% [12,13] – do not exhibit
restricted growth and visible neurological defects [51].
Atp1a3tm1Ling/+ females exhibited deficits in the balance beam
and accelerating rotarod tests only after exposure to restraint stress
for five days [52]. The greater loss of Na+,K+-ATPase activity in
Myk/+ mice offers a plausible, albeit speculative, explanation for
their more severe neurological phenotype. Similar to Myk/+
mutants, Atp1a3tm1Ling/+ mice showed increased locomotor activity
in an open field and some impairment in learning and memory
[13,51]. While novel object recognition memory was normal in
Atp1a3tm1Ling/+ mice, they showed a learning and memory deficit
in the Morris water maze [51], a spatial navigation task that
requires mice to swim in a pool of opaque water. In the present
study, we did test Myk/+ and +/+ mice in the Morris water maze,
but have not presented the data here because there were genotypic
differences in swimming behaviour; Myk/+ mice often displayed
undirected swimming in tight circles (Video S3).
Another mouse model employs a pharmacological approach to
perturb Na+,K+-ATPase function. Perfusion of ouabain into the
cerebellum and basal ganglia has been found to induce mild
dyskinesia in C57BL/6 mice, but when these mice were exposed
to random electric footshocks in a warm environment (38uC) for
2 hours, 70% of them developed persistent dystonia and rigidity
[53]. This pharmacological approach is limited by the ability to
simultaneously target only two brain regions, and the similar
affinities of the a2 and a3 isoforms for ouabain [54], thus
precluding isoform specificity. Hence, Myshkin is the first mouse
model with specific perturbation of Na+,K+-ATPase a3 to exhibit
motor deficits in the absence of experimental stressors, thus
demonstrating a greater similarity of the Myk/+ phenotype to
AHC than RDP.
The most common finding of 2-DG PET scans of AHC patients
is an interictal decrease in brain glucose metabolism [3,5]. Our
finding that glucose metabolism in the Myshkin brain was
decreased in the frontal cortex, multiple thalamic nuclei and
caudal motor cortex, and profoundly increased in the periaque-
ductal grey, is consistent with the variety of phenotypic abnor-
malities exhibited by Myk/+ mice, including the previously
described neuronal hyperexcitability with increased susceptibility
to epileptic seizures [12] and mania-related behaviours such as
sleep disturbances and lengthened circadian period [13]. An
immunohistochemical study of Na+,K+-ATPase a3 expression in
the adult mouse brain showed that Na+,K+-ATPase a3 has a
restricted distribution throughout the brain, with expression
mainly in GABAergic neurones [55]. Among the brain structures
with altered glucose metabolism for which Na+,K+-ATPase a3
expression data were available, Na+,K+-ATPase a3-positive cells
were observed in the frontal association cortex, primary motor
cortex, ventral anterior thalamic nucleus, ventral posteromedial
thalamic nucleus, and dorsomedial periaqueductal grey, but not in
the ventromedial thalamic nucleus [55]. Other brain structures,
such as the basal ganglia and cerebellum involved in movement
control, showed high expression of Na+,K+-ATPase a3 [55], but
did not show altered glucose metabolism in Myk/+ mice.
Therefore, the altered glucose metabolism was not confined to
brain structures expressing Na+,K+-ATPase a3. Of the several
brain regions previously found by MRI to have altered volumes in
Myk/+ mice [12], only the thalamus was found to have altered
glucose metabolism. Indeed, our data highlight the thalamus as
being central to the compromised thalamocortical functioning in
Myk/+ mice that includes a deficit in frontal cortex functioning
(hypofrontality), directly mirroring that reported in AHC [3,5],
along with reduced thalamocortical functional connectivity
(Figure 7). The elucidation of alterations in functional connectivity
between defined brain regions and neural subsystems from 2-DG
brain imaging data has previously been described [25,56,57].
The hypofrontality and frontal cortex dysconnectivity seen in
Myk/+ mutants may directly contribute to the cognitive deficits we
have seen in these mice, as these neural systems have an
established role in associative learning [58], fear conditioning
[59,60] and other high level cognitive processes [56,61]. The
disrupted functional connectivity between the thalamus and basal
ganglia and thalamus and motor cortex that we have identified in
Myk/+ mutants is also consistent with aspects of the motor
dysfunction we have observed in these mice. It is particularly
interesting that Myk/+ mice show increased tremor, as evidence
suggests that the regulation of thalamic circuitry by components of
the basal ganglia plays a central role in regulating tremor
amplitude [62,63]. Overall, these data suggest that disrupted
functional connectivity between these neural systems may underlie
the motor symptoms of Myk/+ mice and, by extension, AHC
patients.
AHC patients exhibit autonomic symptoms, such as alterations
in skin colour, temperature, and sweating, concurrent with
hemiplegia or in isolation [4]. The elevated mean, systolic, and
diastolic blood pressure, but normal heart rate, of Myk/+ mice
compared to +/+ littermates is similar to the effect on
cardiovascular haemodynamics of chronic ICV infusion of
ouabain in wild-type mice [30]. As the ubiquitously expressed
a1 isoform is naturally resistant to ouabain in rodents [64], it is
highly unlikely that it plays a role in ouabain-induced hyperten-
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sion. In contrast, the a2 and a3 isoforms have a high affinity for
ouabain and thereby could mediate the pressor effects of ouabain
[54]. Studies utilizing Atp1a2tm3Ling mice homozygous for a
ouabain-resistant a2 isoform, such that the only ouabain-sensitive
isoform they express in the CNS is a3, found that ICV ouabain did
not raise blood pressure in these mice [30]; this suggested that the
pressor response to ICV ouabain is mediated solely by the a2
isoform in the brain. Nevertheless, our finding of hypertension in
Myk/+ mice suggests that the a3 isoform may also play a role in
the regulation of blood pressure. We previously found that the
antihypertensive agent rostafuroxin [65], which antagonizes the
inhibitory action of ouabain on Na+,K+-ATPase, reduced risk-
taking behaviours in Myk/+ mice [13]. Blood pressure measure-
ments in AHC patients have not been reported.
In summary, we found that Myk/+ mice carrying a Na+,K+-
ATPase a3 missense mutation comparable to mutations observed
in AHC patients exhibit motor and cognitive deficits that model
the most common permanent symptoms of AHC. The Myshkin
mutant is unique in that it is the first model described with an
AHC-relevant phenotype associated with a Na+,K+-ATPase a3
missense mutation. Our results provide biological validation for
heterozygous missense mutations in ATP1A3 as a cause of AHC in
humans, and highlight Myshkin as an aetiologically-relevant model
system for the exploration of disease mechanisms and novel
treatments in AHC. In this vein, we used Myk/+ mice to identify
functional alterations in discrete brain regions and neural circuits
that may underlie the overlapping symptoms presented by Myk/+
mice and AHC patients.
Supporting Information
Figure S1 Pathogenic mutations in mouse and human
Na+,K+-ATPase a3. (A) Alignment of the predicted Na+,K+-
ATPase a3 protein sequences of Homo sapiens (OT-
THUMP00000076119) and Mus musculus (EN-
SMUSP00000079691) surrounding residue I810 mutated in
Myshkin mice. Residues mutated in RDP patients (red text),
AHC patients (blue text) or Myshkin mice (green text) are shown, a
grey background indicating residues mutated in both RDP and
AHC, or in both AHC and Myshkin. Numbers flanking the
alignment show the amino acid position. (B) Structural modelling
of mouse Na+,K+-ATPase a3 wild-type, showing the positions of
the mutated residues and predicted K+ ion binding sites. All the
mutations modelled affect transmembrane helices bordering the
K+ pore.
(PDF)
Figure S2 Gait analysis. (A) Relationship of trunk length to
body weight in Myk/+ and +/+ female mice. Trendlines and
Pearson correlation coefficients (r) are shown. (B) Unadjusted
mean fore stride and hind stride distance (6 SEM) of Myk/+
(n= 14) and +/+ (n= 17) female mice. There were significant main
effects of genotype on fore stride width (F1,30 = 20.76, P= 0.0001),
fore stride length (F1,30 = 42.65, P= 0.0001), and hind stride length
(F1,30 = 42.45, P= 0.0001). ****P,0.0001 versus +/+ mice. (C)
Relationship of fore stride width to trunk length; (D) fore stride
length to trunk length; (E) hind stride width to trunk length; and
(F) hind stride length to trunk length in Myk/+ and +/+ female
mice. Trendlines and Pearson correlation coefficients (r) are
shown.
(PDF)
Figure S3 Behavioural analysis ofMyk/+mice. (A) Motor
learning on the accelerating rotarod. Mean latency (6 SEM) of
Myk/+ (n= 18) and +/+ (n= 21) mice to fall from a rotating rod at
each block of three training trials on five consecutive days. There
were significant main effects of sex (F1,194 = 41.05, P= 0.0001) and
trial block (F4,194 = 13.09, P= 0.0001), but not genotype
(F1,194 = 1.01, P= 0.316) or genotype x sex interaction
(F1,194 = 0.03, P= 0.869). All genotype/sex groups demonstrated
motor learning by having a longer latency to fall on Day 5 than on
Day 1 of training (P= 0.0001). (B) Grip strength. Mean all-four
limb and forelimb grip strength (6 SEM) of male Myk/+ (n= 21),
female Myk/+ (n= 9), male +/+ (n= 29) and female +/+ (n= 16)
mice. Each mouse was given three trials. There was a significant
main effect of genotype on the grip strength of all-four limbs in
males (F1,49 = 10.15, P= 0.003). **P,0.01 versus +/+ males. (C)
Relationship of all-four limb grip strength to body weight, and (D)
forelimb grip strength to body weight in Myk/+ and +/+ mice.
Trendlines and Pearson correlation coefficients (r) are shown. (E)
Fear conditioning with 0.75-mA footshock. Mean freezing levels
(6 SEM) of Myk/+ (n= 22) and +/+ (n= 21) mice at baseline,
during training, and in the contextual and cued conditioning tests.
There were significant main effects of genotype on freezing in the
context test (F1,42 = 16.27, P= 0.0001), and in the cue test before
(Pre-CS; F1,42 = 6.62, P= 0.014) and during (CS; F1,42 = 14.23,
P= 0.001) presentation of the auditory tone. *P,0.05;
***P,0.001; ****P,0.0001 versus +/+ mice. (F) Acoustic startle
response. Mean amplitude of startle response (6 SEM) of Myk/+
males (n= 21), Myk/+ females (n = 17), +/+ males (n = 29) and +/+
females (n = 26) to auditory stimuli at volumes ranging from 70 to
120 dB. There were significant main effects of genotype
(F1,1022 = 5.25, P= 0.022), sex (F1,1022 = 35.34, P= 0.0001), volume
(F10,1022 = 20.12, P= 0.0001), genotype x sex interaction
(F1,1022 = 7.65, P= 0.006) and genotype x volume interaction
(F10,1022 = 3.39, P= 0.0001). ****P,0.0001 versus +/+ males.
(PDF)
Figure S4 Elevated arterial blood pressure in Myk/+
mice. Mean, systolic, and diastolic arterial pressure (6 SEM) in
millimetres of mercury (mm Hg) of Myk/+ (n = 3) and +/+ (n = 3)
male mice. There were significant main effects of genotype on
mean arterial pressure (Mean BP; P= 0.015), systolic arterial
pressure (Systolic BP; P= 0.004) and diastolic arterial pressure
(Diastolic BP; P= 0.034). *P,0.05; ***P,0.001 versus +/+ mice.
(PDF)
Table S1 Full data for overt cerebral glucose metabo-
lism. Bold denotes regions showing significantly different overt
cerebral metabolism in Myk/+ as compared to +/+ mice. *denotes
P,0.05, **denotes P,0.01 and ***denotes P,0.001 significant
difference from wild-type control (Welch’s t-test).
(PDF)
Table S2 Full data for frontal cortex (FCTX) functional
connectivity. Data shown as the mean 6 SEM of the VIP
statistic as determined through PLSR analysis. Bold denotes
significant functional connection with the defined seed region in
given experimental group (95% CI VIP.0.80). *denotes P,0.05
significant difference in VIP statistic between genotypes (1000
random permutations). Red highlights regions showing increased
and blue decreased functional connectivity with the given seed
brain region in Myshkin (Myk/+) mice relative to wild-type (+/+)
controls.
(PDF)
Table S3 Full data for ventral anterior thalamus
(VAthal) functional connectivity. Data shown as the mean
6 SEM of the VIP statistic as determined through PLSR analysis.
Bold denotes significant functional connection with the defined
seed region in given experimental group (95% CI VIP.0.80).
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*denotes P,0.05 significant difference in VIP statistic between
genotypes (1000 random permutations). Red highlights regions
showing increased and blue decreased functional connectivity with
the given seed brain region in Myshkin (Myk/+) mice relative to
wild-type (+/+) controls.
(PDF)
Table S4 Full data for ventromedial thalamus (VMthal)
functional connectivity. Data shown as the mean 6 SEM of
the VIP statistic as determined through PLSR analysis. Bold
denotes significant functional connection with the defined seed
region in given experimental group (95% CI VIP.0.80). *denotes
P,0.05 significant difference in VIP statistic between genotypes
(1000 random permutations). Red highlights regions showing
increased and blue decreased functional connectivity with the
given seed brain region in Myshkin (Myk/+) mice relative to wild-
type (+/+) controls.
(PDF)
Table S5 Full data for ventral posteromedial nucleus
(VPMthal) functional connectivity. Data shown as the mean
6 SEM of the VIP statistic as determined through PLSR analysis.
Bold denotes significant functional connection with the defined
seed region in given experimental group (95% CI VIP.0.80).
*denotes P,0.05 significant difference in VIP statistic between
genotypes (1000 random permutations). Red highlights regions
showing increased and blue decreased functional connectivity with
the given seed brain region in Myshkin (Myk/+) mice relative to
wild-type (+/+) controls.
(PDF)
Table S6 Full data for dorsomedial periaqueductal grey
(DMPAG) functional connectivity. Data shown as the mean
6 SEM of the VIP statistic as determined through PLSR analysis.
Bold denotes significant functional connection with the defined
seed region in given experimental group (95% CI VIP.0.80).
*denotes P,0.05 significant difference in VIP statistic between
genotypes (1000 random permutations). Red highlights regions
showing increased and blue decreased functional connectivity with
the given seed brain region in Myshkin (Myk/+) mice relative to
wild-type (+/+) controls.
(PDF)
Table S7 Full data for rostral periaqueductal grey
(RPAG) functional connectivity. Data shown as the mean
6 SEM of the VIP statistic as determined through PLSR analysis.
Bold denotes significant functional connection with the defined
seed region in given experimental group (95% CI VIP.0.80).
*denotes P,0.05 significant difference in VIP statistic between
genotypes (1000 random permutations). Red highlights regions
showing increased and blue decreased functional connectivity with
the given seed brain region in Myshkin (Myk/+) mice relative to
wild-type (+/+) controls.
(PDF)
Table S8 Full data for caudal motor cortex (CMCTX)
functional connectivity. Data shown as the mean 6 SEM of
the VIP statistic as determined through PLSR analysis. Bold
denotes significant functional connection with the defined seed
region in given experimental group (95% CI VIP.0.80). *denotes
P,0.05 significant difference in VIP statistic between genotypes
(1000 random permutations). Red highlights regions showing
increased and blue decreased functional connectivity with the
given seed brain region in Myshkin (Myk/+) mice relative to wild-
type (+/+) controls.
(PDF)
Video S1 Movement of representative Myk/+ and +/+
mice in the home cage. Note the unsteady, tremorous gait of
the Myk/+ mouse. [AVI file; Duration: 00:00:30].
(AVI)
Video S2 Representative Myk/+ mouse with splayed
hindlimbs when walking. [AVI file; Duration: 00:00:10].
(AVI)
Video S3 Abnormal swimming behaviour of represen-
tative Myk/+ mouse. [AVI file; Duration: 00:00:33].
(AVI)
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